Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
14.28
-0.29 (-1.99%)
At close: May 30, 2025, 4:00 PM
14.25
-0.03 (-0.21%)
After-hours: May 30, 2025, 4:36 PM EDT
Edgewise Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$40.13
Upside
+181.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $43 | Buy | Maintains | $43 | +201.12% | Apr 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $56 → $52 | Buy | Maintains | $56 → $52 | +264.15% | Apr 3, 2025 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $50 → $14 | Buy → Hold | Downgrades | $50 → $14 | -1.96% | Apr 3, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 | Buy | Maintains | $51 | +257.14% | Apr 2, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +250.14% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $56 | Buy | Reiterates | $56 | +292.16% | Mar 4, 2025 |
| Stifel | Stifel | Hold Initiates $30 | Hold | Initiates | $30 | +110.08% | Jan 22, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +250.14% | Dec 17, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $33 → $50 | Strong Buy | Maintains | $33 → $50 | +250.14% | Nov 27, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $45 | Buy | Initiates | $45 | +215.13% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Maintains $44 → $45 | Buy | Maintains | $44 → $45 | +215.13% | Nov 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $48 → $51 | Buy | Maintains | $48 → $51 | +257.14% | Oct 11, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $42 | Buy | Maintains | $32 → $42 | +194.12% | Sep 20, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $33 | Strong Buy | Maintains | $25 → $33 | +131.09% | Sep 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $32 | Buy | Maintains | $32 | +124.09% | Sep 17, 2024 |
| Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | +117.09% | Aug 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.